Stocks in news: RIL, Tata Motors, Ola Electric, Dilip Buildcon, Sun Pharma
Markets started the week on a volatile note and gained over a percent, snapping their recent losing streak, supported by bargain buying. On the index front, the rebound helped the Nifty move back above the 23,300 mark after testing sub-23,000 levels intraday.
However, analysts say investors should not read too much into a single-day bounce and should wait for the sustainability of the move, as the index continues to trade below key resistance zones.
In today's trade, shares of RIL, Tata Motors, Ola Electric, Dilip Buildcon, Sun Pharma among others will be in focus due to various news developments.
Tejas Networks
Tejas Networks has secured a purchase order to supply 4G Radio Access Network (RAN) solutions for a mobile operator in South Asia, the company said in a press release. Under the order, the company's 4G multiband radio products will be deployed across multiple sites in the operator's network. The financial terms and the name of the operator were not disclosed.
Dilip Buildcon
The National Company Law Appellate Tribunal (NCLAT) on Monday restored an insolvency appeal against Dilip Buildcon, a construction and infrastructure development company. A two-member bench of the NCLAT on December 12 last year, dismissed the appeal filed by Shyamji Construction Co against Dilip Buildcon on the ground of 'non-prosecution'.
RIL
Reliance Industries Limited (RIL) on Monday said it has signed a binding long-term agreement to supply green ammonia to South Korea’s Samsung C&T Corporation, marking one of the world’s largest such deals in the emerging green fuels market.
Sun Pharma
India’s largest drugmaker Sun Pharmaceutical has received a nod from the US Food and Drug Administration (USFDA) to expand the therapeutic use of its innovative drug Ilumya for the treatment of adults with active psoriatic arthritis. The US regulator has accepted Sun’s supplemental Biologics License Application (sBLA) for review, the company said.
Tata Motors
Tata Motors on Monday announced an increase in prices of commercial vehicles by up to 1.5% with effect from April 1, in order to offset rising commodity prices and input costs. The price hike is being undertaken to partially offset the impact of rising commodity prices and other input costs, Reuters reported.
Ola Electric
Ola Electric has kicked off a plan to raise up to Rs 2,000 crore by selling a stake in its battery arm, Ola Cell Technologies (OCT), PTI reported. OCT owns the Tamil Nadu-based lithium-ion cell manufacturing plant with 1.5 GWh of operational capacity and plans to scale to 6 GWh by the end of this financial year.
However, analysts say investors should not read too much into a single-day bounce and should wait for the sustainability of the move, as the index continues to trade below key resistance zones.
In today's trade, shares of RIL, Tata Motors, Ola Electric, Dilip Buildcon, Sun Pharma among others will be in focus due to various news developments.
Tejas Networks
Tejas Networks has secured a purchase order to supply 4G Radio Access Network (RAN) solutions for a mobile operator in South Asia, the company said in a press release. Under the order, the company's 4G multiband radio products will be deployed across multiple sites in the operator's network. The financial terms and the name of the operator were not disclosed.
Dilip Buildcon
The National Company Law Appellate Tribunal (NCLAT) on Monday restored an insolvency appeal against Dilip Buildcon, a construction and infrastructure development company. A two-member bench of the NCLAT on December 12 last year, dismissed the appeal filed by Shyamji Construction Co against Dilip Buildcon on the ground of 'non-prosecution'.
RIL
Reliance Industries Limited (RIL) on Monday said it has signed a binding long-term agreement to supply green ammonia to South Korea’s Samsung C&T Corporation, marking one of the world’s largest such deals in the emerging green fuels market.
Sun Pharma
India’s largest drugmaker Sun Pharmaceutical has received a nod from the US Food and Drug Administration (USFDA) to expand the therapeutic use of its innovative drug Ilumya for the treatment of adults with active psoriatic arthritis. The US regulator has accepted Sun’s supplemental Biologics License Application (sBLA) for review, the company said.
Tata Motors
Tata Motors on Monday announced an increase in prices of commercial vehicles by up to 1.5% with effect from April 1, in order to offset rising commodity prices and input costs. The price hike is being undertaken to partially offset the impact of rising commodity prices and other input costs, Reuters reported.
Ola Electric
Ola Electric has kicked off a plan to raise up to Rs 2,000 crore by selling a stake in its battery arm, Ola Cell Technologies (OCT), PTI reported. OCT owns the Tamil Nadu-based lithium-ion cell manufacturing plant with 1.5 GWh of operational capacity and plans to scale to 6 GWh by the end of this financial year.
Next Story